View drug registration information details.


ItemsRegistration information
ID1256
No1256
Brand NameLAKAS TABLET 10 MG
IngredientsMONTELUKAST SODIUM EQ. TO MONTELUKAST 10 MG
Dosage FormTABLET
Primary PackagingALU-ALU
StorageSTORE BELOW 30 C
Shelf Life2 YEARS
Pack Size1 X 10'S/BOX
Dispensing CategoryPrescription only
ATC ClassificationXX
Pharmaceutical ClassANTIASTHMA
IndicationsTREATMENT OF ASTHMA AS ADD-ON THERAPY IN ADULTS AND CHILDREN WITH MILD TO MODERATE PERSISTENT ASTHMA WHO ARE INADEQUATELY CONTROLLED ON INHALED CORTICOSTEROID AND IN WHOM AS NEEDED SHORT ACTING BETA-AGONISTS PROVIDE INADEQUATE CLINICAL CONTROL OF ASTHMA.
ContraindicationsHYPERSENSITIVITY
Side EffectsUPPER RESPIRATORY INFECTION, FEVER, HEADACHE, PHARYNGITIS, COUGH, ABDOMINAL PAIN, DIARRHOEA, OTITIS MEDIA, INFLUENZA, SINUSITIS
Unit Price0.48$
EDL Yes
DescriptionOFF WHITE COLORED ROUND SHAPED BICONVEXED TABLETS PLAIN ON BOTH SIDE
Note
License OwnerKONGCHAI-LAO PHARMA SOLE CO.,LTD
ManufacturerFOCUS & RULZ PHARMACEUTICALS (PVT) LTD
CountryPAKISTAN
Import Registration No49294
Import Registration Date2008-07-10
ActivityCERTIFICATE RELEASED
Applied Date2024-03-22
FDD Registration No04 I 4667/19
FDD Registration Date2024-06-22
Expiry Date2027-06-21

Back to drug list